IRVINE, Calif., July 25, 2023 – The board of directors of TAE Life Sciences, a pre-clinical stage biotech company focused on advancing the field of radiation oncology through accelerator-based Boron Neutron Capture Therapy (BNCT), is pleased to announce the appointment of Rob Hill as its new Chief Executive Officer (CEO). Effective immediately, Hill succeeds Bruce Bauer who has served as CEO since the company was founded in 2017. Bauer, stepping aside for medical reasons, will remain active on the board of directors as chairman emeritus.
The Board of Directors is grateful to Bauer for his significant contributions as CEO. Under his leadership, TAE Life Sciences licensed its accelerator technology from TAE Technologies, the world’s largest and most advanced private fusion energy company, secured Series A and Series B funding, developed and deployed its first neutron beam system, arranged strategic partnerships with world-renowned cancer centers for clinical trials, and envisioned and established a world-class pharmaceutical development team.
With an impressive track record in the radiation oncology industry and extensive experience in corporate strategy, product development, and global market expansion, Hill brings invaluable expertise to his new role as CEO of TAE Life Sciences. His deep understanding of the industry, coupled with his visionary leadership, will play a pivotal role in propelling the company forward as it enters the critical clinical trial phase for its groundbreaking Alphabeam™ BNCT system with its novel targeted boron drugs.
Having joined TAE Life Sciences as Chief Operating Officer in October 2018, Hill has already made significant contributions to the company’s growth and success. Under his leadership, TAE successfully delivered its neutron beam system and accelerator to its joint-venture partner in China, overcoming many challenges posed by the global pandemic. He also played a crucial role in securing partnerships with prominent medical institutions and medical distribution partners from around the world, growing the company’s R&D organization, and fundraising for the company.
“I am truly honored to lead TAE Life Sciences, a company poised to revolutionize cancer treatment and save countless lives,” said Hill. “I’m confident that our Alphabeam BNCT machine, combined with our proprietary targeted drugs, will profoundly impact the lives of patients worldwide. With our exceptional team, we’ll bring this groundbreaking therapy to market, and make a meaningful difference in the fight against cancer.”
Before joining TAE Life Sciences, Hill held various senior executive positions at Accuray Incorporated, a renowned provider of radiation oncology solutions. During his tenure, he led the development and launch of innovative products, drove strategic partnerships, and played a crucial role in transforming the company’s product development organization. His accomplishments at Accuray include launching new radiation therapy products, intellectual property development, and driving significant revenue growth.
Under Hill’s leadership, TAE Life Sciences is well-positioned to achieve its strategic goals, commence clinical trials globally, and become a global leader in the radiation oncology market with its Alphabeam BNCT system and novel targeted boron drugs.
Click here to view TAE Life Sciences’ latest video where Rob Hill presents his vision of how TAE Life Sciences is reinventing radiation therapy for cancer patients.
About TAE Life Sciences
TAE Life Sciences is a privately held biotechnology company committed to developing a new biologically targeted radiation therapy based on Boron Neutron Capture Therapy (BNCT). TAE Life Sciences is the only company developing the next-generation targeted boron drugs and low-energy accelerator-based neutron system optimized for an in-hospital BNCT program that delivers cancer-killing radiation with cellular-level precision to treat patients with aggressive and refractory cancers. TAE Life Sciences’ Alphabeam neutron system and targeted boron drugs are currently in development and have not been approved for sale. More information about TAE Life Sciences is available at www.taelifesciences.com.
TEL AVIV, July 20, 2023 – SolidRun, a leading developer and manufacturer of high-performance System on Module (SOM) solutions, Single Board Computers (SBC) and network edge solutions, today announced the expansion of its SolidWAN line of software-defined network appliances with the introduction of the SolidWAN CN9131. Building on the success of the previously launched SolidWAN system-level solutions for software-defined wide area networks and network security applications, the SolidWAN CN9131 sets a new standard for small form factor SD-WAN hardware solutions.
“As businesses worldwide embrace the transformative power of software-defined networking, the need for adaptable and cost-effective network hardware becomes increasingly crucial,” said Dr. Atai Ziv, CEO at SolidRun. “SolidRun understands that a one-size-fits-all approach doesn’t meet the diverse requirements of connecting today’s businesses and distributed workforce. That’s why we’ve developed our SolidWAN line of SD-WAN appliances. By making software-defined solutions more affordable and easily deployable across home offices, branch offices, data centers, and beyond, we empower businesses to build agile and scalable networks that drive efficiency, security, and seamless connectivity.”
SD-WAN technology revolutionizes traditional networking by providing enhanced performance, flexibility, and cost-effectiveness. With their vast software-defined capabilities, SolidRun’s SolidWAN solutions simplify network management, increase network agility, and improve application performance across multiple locations. These solutions are particularly crucial for businesses with distributed branch offices, enabling them to centralize control, optimize bandwidth usage, and secure their networks effectively.
SolidWAN network hardware solutions are optimized for software-defined networking applications and provide direct connectivity of network ports to the CPU. This direct connection allows all network traffic to be managed by software, which not only guarantees the highest security and best possible quality of service, but also makes upgrading network hardware, deploying updates and establishing new network services fast and easy.
The embedded Marvell OCTEON CN9131 SoC is designed to address the specific networking requirements of small to medium businesses (SMBs). With its powerful quad-core performance and 12 high-speed SERDES lanes, the SoC delivers exceptional processing power for network data management and security. It features a configurable packet processor, allowing for flexible parsing and classification of network traffic, supports I/O virtualization, enabling efficient resource allocation, and includes QoS buffer management and a virtual security engine and packet processor for enhanced security measures. Each unit features 8GB of eMMC storage, 4GB DDR4 RAM and 8MB SPI NOR Flash memory.
“With its powerful quad-core performance, versatile packet processor, and robust embedded security features, the CN9131 was engineered to tackle complex networking challenges with ease,” said Rabeeh Khoury, CTO at SolidRun. “By harnessing the capabilities of the CN9131, SolidRun’s SolidWAN CN9131 SD-WAN appliance enables businesses to optimize their network performance, enhance security, and drive operational efficiency. Like Marvell, SolidRun is committed to creating powerful solutions that shape the future of network management and empower organizations to thrive in today’s interconnected world.”
“With its best-in-class performance/Watt and vast IO flexibility, the CN913x family of SoCs is the ideal choice for small form factor SD-WAN products like SolidRun’s SolidWAN CN9131 appliance,” said Jeffrey Ho, director of product marketing, Marvell Semiconductor.
The SolidWAN CN9131 offers a variety of connectivity options to meet diverse networking needs, including two SFP+ 10GbE ports, which provide high-speed connectivity for data transmission and four 1000BASE-T gigabit Ethernet ports, ideal for establishing fast data connections. For wireless connectivity, the device comes equipped with an mPCIe WiFi AP module, allowing wireless access point functionality. It also includes an M.2 SIM holder, enabling LTE connectivity for mobile networks. To accommodate additional storage and peripherals, the device offers a uSD slot, 2 USB 3.0 ports and two M.2 slots for internal storage (1 Key M and 1 Key B).
As with many SolidRun network hardware solutions, the SolidWAN family of products offers SKUs that support a wide range of deployment environments and can be pre-configured for commercial applications where environmental conditions range between 0°C to 40°C, or for more extreme industrial applications where conditions range between -20°C to 65°C. All configurations feature a fanless design with a heat-shedding, finned aluminum enclosure.
SolidWAN products are compatible with Linux-based software applications, including DPDK, which provides data plane libraries and network interface controller polling-mode drivers for offloading TCP packet processing from the operating system kernel to processes running in user space. SolidRun has also partnered with several software developers to offer full SD-WAN and security service software to customers.
SolidRun is a global leading developer of embedded systems and network solutions, focused on a wide range of energy-efficient, powerful, and flexible products. Our innovative compact embedded solutions are based on ARM and x86 architecture and offer a variety of platforms including SOMs (System-on-Module), SBCs (Single Board Computer) and industrial mini-PCs.
SolidRun offers a one-stop-shop for developers and OEMs, providing a complete service from hardware customization to software support and even product branding and enclosure design. With a mission to simplify application development while overcoming deployment challenges, SolidRun proudly provides customers faster time-to-market and lower costs.
